LIVE ONLINE Conference Programme

default

Loading

Covid Research - Part 1

04 Nov 2021
Covid Research

(Timings are in Greenwich Mean Time - add session to your diary using link below)

Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial

Introduction:  Effective treatment for patients with the novel Coronavirus Disease (COVID-19) is desperately needed and is under rigorous research. Nigella sativa oil (NSO), a herbal medicine, that has a documented wide antiviral and immunomodulatory activities offering a therapeutic potential for COVID-19. 

Speakers
Dr Abdulrahman Koshak, Research, King Abdulaziz University - Saudi Arabia

The joint congress for ESIM and ISCMR:

Organised in association with:

Gold Sponsors:


 

Silver Sponsors:


 

Supported by: